istradefylline (Nourianz)
Jump to navigation
Jump to search
Indications
- add-on treatment to levodopa/carbidopa in adult patients with Parkinson's disease experiencing 'off' episodes
Adverse effects
Mechanism of action
More general terms
References
- ↑ FDA News Release. Aug 27, 2019 FDA approves new add-on drug to treat off episodes in adults with Parkinson's disease. https://www.fda.gov/news-events/press-announcements/fda-approves-new-add-drug-treat-episodes-adults-parkinsons-disease